← Eichor
Condition: Stage Ii Ovary Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stage Ii Ovary Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Pr
Phase 1/Phase 2 · 4 location(s) · Imunon · NCT05739981Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cance
Phase 2 · 1 location(s) · Bai-Rong Xia · NCT07125391Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Phase 2 · 14 location(s) · MedSIR · NCT06180356Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07144826Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Phase 2 · 12 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05872204Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT03412877CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
Phase 2 · 2 location(s) · Ira Winer · NCT04055649A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Phase 1/Phase 2 · 4 location(s) · Cancer Research UK · NCT06380816Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · NCT06819215An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV
NA · 1 location(s) · Roswell Park Cancer Institute · NCT06855706Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Phase 1/Phase 2 · 3 location(s) · Filamon LTD · NCT06926075A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Phase 2 · 17 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT06434610Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Phase 1/Phase 2 · 14 location(s) · Volastra Therapeutics, Inc. · NCT05902988A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patien
Phase 1/Phase 2 · 1 location(s) · Shenzhen Ionova Life Sciences Co., Ltd. · NCT07610798A Study of Intra-operative Imaging in Women With Ovarian Cancer
Phase 3 · 9 location(s) · Memorial Sloan Kettering Cancer Center · NCT04878094Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites
Phase 1/Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07435701Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
Phase 1/Phase 2 · 1 location(s) · University of California, Irvine · NCT04520139Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer
Phase 2 · 1 location(s) · National Cancer Center, Korea · NCT07171528Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High
Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT06083844Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TRO
Phase 2 · 96 location(s) · AstraZeneca · NCT05489211Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NA · 1 location(s) · Shanghai Gynecologic Oncology Group · NCT05236686HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Phase 2 · 1 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT03275194Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT05952453Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade En
Phase 2 · 1 location(s) · University College, London · NCT05080556Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
Phase 2 · 6 location(s) · The University of Hong Kong · NCT07023484Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
Phase 2 · 4 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07303387Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma
Phase 2 · 17 location(s) · Italian Sarcoma Group · NCT04383119QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Phase 2 · 1 location(s) · Affiliated Cancer Hospital & Institute of Guangzhou Medical · NCT07286240
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.